(Q29620648)

English

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

scientific article (publication date: August 2011)

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study (English)

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21783417

30 April 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Caicun Zhou

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Gongyan Chen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jifeng Feng

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Xiao-Qing Liu

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Changli Wang

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Shucai Zhang

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jie Wang

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Songwen Zhou

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Shengxiang Ren

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Shun Lu

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Li Zhang

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Chengping Hu

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Chunhong Hu

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yi Luo

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Lei Chen

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ming Ye

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jianan Huang

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Xiuyi Zhi

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yiping Zhang

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Qingyu Xiu

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jun Ma

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Li Zhang

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Changxuan You

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21783417

30 April 2017

publication date

23 July 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Lancet Oncology Commission

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21783417

30 April 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

12

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21783417

30 April 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

735-742

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

8

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21783417

30 April 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for epidermal growth factor receptor mutations in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of the cutaneous side effects of therapeutic epidermal growth factor receptor inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970184-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(11)70184-X

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21783417

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21783417

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21783417%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29620648&oldid=1743639443"